The Board of Directors of Panacea Biotec has appointed Narotam Kumar Juneja as an additional director (in the capacity of Non-Executive Non-Independent Director) on the Board of Directors of the Company with effect from April 01, 2022.

Narotam Kumar Juneja has done Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations. He has rich experience of over 40 years in pharmaceutical operations and has executed multiple internationally approved projects worth over US $ 150 million for reputed companies.

He has earlier been associated with the company as Vice President Operations & Projects during 2003-2006 and again as Chief Operating Officer during 2010-2014. He has also worked in senior positions with Dawa Group, Kenya and several other companies in India including Unichem Laboratories, Ranbaxy Laboratories, Systopic India and Dabur India.